会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Synergistine derivatives and their preparation
    • 协同主义衍生物及其制备
    • US4617377A
    • 1986-10-14
    • US630256
    • 1984-07-12
    • Jean-Pierre CorbetClaude CotrelDaniel FargeJean-Marc Paris
    • Jean-Pierre CorbetClaude CotrelDaniel FargeJean-Marc Paris
    • C07D498/14A61K38/00C07K7/06C07K5/12
    • C07K7/06A61K38/00Y10S930/19Y10S930/27
    • The invention provides new synergistine derivatives of the formula: ##STR1## in which Y=H or N(CH.sub.3).sub.2 and R represents: (a) H or OH,(b) a radical of the formula NR.sub.1 R.sub.2, in which R.sub.1 and R.sub.2 =H, phenyl or pyridyl (optionally substituted by dialkylamino (1 to 4 C), alkyl (1 to 10 C) [optionally substituted by OH, SH, COOH, anilino, or alkylamino or dialkylamino of which at least one of the alkyl parts is substituted by OH, SH, COOH or anilino 9 , alkenyl (3 or 4 C) or alkynyl (3 or 4 C), or alternatively R.sub.1 and R.sub.2 together form a heterocycle optionally containing another heteroatom such as O, S or N (optionally substituted by alkyl), or(c) a halogen atom, a trimethylsilyloxy or dialkylphosphoryloxy radical or a radical --OSO.sub.2 R.sub.3 or --OCOR.sub.4, R.sub.3 being alkyl, trifluoromethyl, trichloromethyl or optionally substituted phenyl and R.sub.4 being defined in the same way as R.sub.3 or being an acylalkyl, alkoxycarbonylalkyl or alkoxy radical, and also their salts and their preparation. These products are useful as intermediates in the synthesis of anti-bacterial synergistine derivatives.
    • 本发明提供下式的新的增效剂衍生物:其中Y = H或N(CH 3)2,R代表:(a)H或OH,(b)式NR1R2的基团,其中Y = H或N(CH3) R 1和R 2 = H,苯基或吡啶基(任选被二烷基氨基(1至4 C)取代),(1至10 C)烷基(任选被OH,SH,COOH,苯胺基或烷基氨基或二烷基氨基取代, 烷基部分被OH,SH,COOH或苯胺基9,烯基(3或4 C)或炔基(3或4 C)取代,或者R 1和R 2一起形成任选地含有另外的杂原子如O,S或 N(任选被烷基取代),或(c)卤素原子,三甲基甲硅烷氧基或二烷基磷酰氧基或基团-OSO 2 R 3或-OCOR 4,R 3是烷基,三氟甲基,三氯甲基或任选取代的苯基,并且R 4的定义同 R3或为酰基烷基,烷氧基羰基烷基或烷氧基,以及它们的盐及其制备 ul作为抗菌增效剂衍生物合成中的中间体。
    • 3. 发明授权
    • Pristinamycin derivatives, their preparation and their use
    • 普瑞霉素衍生物,其制备及其应用
    • US4590004A
    • 1986-05-20
    • US630284
    • 1984-07-12
    • Jean-Pierre CorbetClaude CotrelDaniel FargeJean-Marc Paris
    • Jean-Pierre CorbetClaude CotrelDaniel FargeJean-Marc Paris
    • C07D498/18A61K9/08A61K31/42A61K38/00A61P31/04C07D498/20C07K5/078C07K7/06C07K5/12
    • C07K5/06182C07K7/06A61K38/00Y10S930/19Y10S930/27
    • The invention provides new pristinamycin II.sub.B derivatives of the formula: ##STR1## in which R represents alkylthio substituted by (i) alkylamino or dialkylamino of which the alkyl parts can form a pyrrolidin-1-yl, piperidino, azetidin-1-yl, azepin-1-yl, morpholino, thiomorpholino or piperazin-1-yl ring (optionally substituted by alkyl), or (ii) pyrrolidin-2-yl or pyrrolidin-3-yl, piperidin-2-yl, piperidin-3-yl or piperidin-4-yl, azetidin-2-yl or azetidin-3-yl or azepin-2-yl, azepin-3-yl or azepin-4-yl;a radical Het-S-, in which Het is pyrrolidin-3-yl, piperidin-3-yl or piperidin-4-yl, azetidin-3-yl or azepin-3-yl or azepin-4-yl optionally N-alkylsubstituted; ordialkylamino of which the alkyl parts can form a pyrrolidin-1-yl, piperidino, azetidin-1-yl, azepin-1-yl, morpholino, thiomorpholino or piperazin-1-yl ring (optionally substituted by alkyl), the said alkyls having 1 to 5 carbon atoms each in a linear or branched chain. The compounds of the formula (I) are useful as antimicrobial agents when used in association with known synergistines or synergistines of the formula: ##STR2##
    • 本发明提供了下式的新霉素霉素IIB衍生物:其中R表示被(i)烷基氨基或二烷基氨基取代的烷硫基,其烷基部分可以形成吡咯烷-1-基,哌啶子基,氮杂环丁烷-1-基, 哌嗪-1-基,吗啉代,硫代吗啉代或哌嗪-1-基环(任选被烷基取代),或(ii)吡咯烷-2-基或吡咯烷-3-基,哌啶-2-基,哌啶-3-基 - 基或哌啶-4-基,氮杂环丁烷-2-基或氮杂环丁烷-3-基或氮杂-2-基,吖庚因-3-基或氮杂-4-基; 基团Het-S-,其中Het是吡咯烷-3-基,哌啶-3-基或哌啶-4-基,氮杂环丁烷-3-基或吖庚因-3-基或氮杂-4-基任选N-烷基取代 ; 或其二烷基氨基,其烷基部分可以形成吡咯烷-1-基,哌啶子基,氮杂环丁烷-1-基,吖庚因-1-基,吗啉代,硫代吗啉代或哌嗪-1-基环(任选被烷基取代),所述烷基 具有1至5个碳原子,各自为直链或支链。 当与已知的下式的增效剂或增效剂结合使用时,式(I)的化合物可用作抗微生物剂:(V)
    • 5. 发明授权
    • Synergistine derivatives having anti-bacterial activity and their use
    • 具有抗菌活性的协同主义衍生物及其用途
    • US4618599A
    • 1986-10-21
    • US630288
    • 1984-07-12
    • Jean-Pierre CorbetClaude CotrelDaniel FargeJean-Marc Paris
    • Jean-Pierre CorbetClaude CotrelDaniel FargeJean-Marc Paris
    • C07D498/14A61K31/435A61K38/00A61P31/04C07D20060101C07D213/65C07D273/00C07D498/18C07K7/00C07K7/06A61K37/02C07K5/12
    • C07K7/06A61K38/00Y10S930/19Y10S930/27
    • The invention provides new synergistine derivatives of the formula: ##STR1## in which Y=H or N(CH.sub.3).sub.2 and (a) R.sub.1 and R.sub.2 =H and R=pyrrolidin-3-ylthio or piperidin-3-ylthio or piperidin-4-ylthio (optionally substituted by alkyl), or altenatively R=alkylthio substituted by 1 or 2 SO.sub.3 H radicals or alkylamino or dialkylamino radicals (optionally substituted) or by 1 or 2 piperazino rings (optionally substituted) or morpholino, thiomorpholino, piperidino, pyrrolidin-1-yl, piperidin-2-yl, piperidin-3-yl or piperidin-4-yl or pyrrolidin-2-yl or pyrrolidin-3-yl rings (these last 5 rings being optionally substituted by alkyl), or(b) R.sub.1 and R.sub.2 form a bond and R=pyrrolidin-3-ylamino, piperidin-3-ylamino or piperidin-4-ylamino, pyrrolidin-3-yloxy, piperidin-3-yloxy or piperidin-4-yloxy, pyrrolidin-3-ylthio, piperidin-3-ylthio or piperidin-4-ylthio (optionally substituted by alkyl), or alternatively R=alkylamino, alkoxy or alkylthio substituted by 1 or 2 SO.sub.3 H radicals, alkylamino or dialkylamino radicals (optionally substituted) or trialkylammonio or imidazol-4-yl or imidazol-5-yl radicals or by 1 or 2 piperazino rings (optionally substituted by alkyl) or morpholino, thiomorpholino, piperidino, pyrrolidin-1-yl, piperidin-2-yl, piperidin-3-yl or piperidin-4-yl or pyrrolidin-2-yl or pyrrolidin-3-yl rings (these last two rings being optionally substituted by alkyl), and their salts, their preparation, and the pharmaceutical compositions in which they are present. These compounds are useful as anitbacterial agents.
    • 本发明提供下式的新增效剂衍生物:其中Y = H或N(CH 3)2和(a)R 1和R 2 = H,R =吡咯烷-3-基硫代或哌啶-3-基硫基 或哌啶-4-基硫代(任选被烷基取代),或惰性地R =被1或2个SO 3 H基团取代的烷硫基或烷基氨基或二烷基氨基(任选取代的)或1或2个哌嗪子基环(任选取代的)或吗啉代,硫代吗啉代, 哌啶子基,吡咯烷-1-基,哌啶-2-基,哌啶-3-基或哌啶-4-基或吡咯烷-2-基或吡咯烷-3-基环(这5个环任选被烷基取代) 或(b)R 1和R 2形成键,R =吡咯烷-3-基氨基,哌啶-3-基氨基或哌啶-4-基氨基,吡咯烷-3-基氧基,哌啶-3-基氧基或哌啶-4-基氧基,吡咯烷 -3-烷硫基(任选被烷基取代),或者R =被1或2个SO 3 H基取代的烷基氨基,烷氧基或烷硫基,烷基氨基或二烷基氨基 (任选取代的)或三烷基氨基或咪唑-4-基或咪唑-5-基或1或2个哌嗪子基环(任选被烷基取代)或吗啉代,硫代吗啉代,哌啶子基,吡咯烷-1-基,哌啶-2-基, 哌啶-3-基或哌啶-4-基或吡咯烷-2-基或吡咯烷-3-基环(这些最后两个环任选被烷基取代),及其盐,它们的制备和药物组合物 他们在场。 这些化合物可用作厌氧细菌剂。
    • 6. 发明授权
    • Synergistine derivatives, their preparation and pharmaceutical
compositions containing them
    • 协同三烯衍生物,它们的制备和含有它们的药物组合物
    • US4617290A
    • 1986-10-14
    • US630245
    • 1984-07-12
    • Jean-Pierre CorbetClaude CotrelDaniel FargeJean-Marc Paris
    • Jean-Pierre CorbetClaude CotrelDaniel FargeJean-Marc Paris
    • C07D498/14A61K31/435A61K38/00A61P31/04C07K7/06A61K37/02C07K5/12
    • C07K7/06A61K38/00
    • The invention provides novel synergistine derivatives of the formula: ##STR1## in which Y=H or N(CH.sub.3).sub.2 : and R.sub.1 =H and R.sub.2 =OH or alkyl optionally substituted by COOH, alkoxycarbonyl or OH or by alkylamino or dialkylamino the alkyl radicals of which can form a heterocycle, or R.sub.2 =cycloalkyl (of 3 to 7 carbons) or a heterocycle chosen from azetidine, pyrrolidine, piperidine or azepine (optionally substituted on the nitrogen by alkyl), or R.sub.1 =formyl or alkylcarbonyl and R.sub.2 =alkyl substituted by COOH or by alkylamino or dialkylamino the alkyl radicals of which can form a heterocycle, or R.sub.2 is a heterocycle as defined above, or R.sub.1 and R.sub.2, which are identical or different, represent alkyl optionally substituted by COOH, alkoxycarbonyl, OH, alkylamino, or dialkylamino of which the alkyl radicals can form a heterocycle, or R.sub.1 and R.sub.2 form an azetidine, pyrrolidine, piperidine, morpholine or piperazine ring (optionally substituted by alkyl), all the alkyls having 1 to 5 carbon atoms. These compounds are useful as antibacterial agents.
    • 本发明提供了下式的新型增效剂衍生物:其中Y = H或N(CH 3)2:和R 1 = H且R 2 = OH或任选被COOH,烷氧基羰基或OH取代的烷基或烷基氨基或 二烷基氨基,其烷基可以形成杂环,或R2 =环烷基(3至7个碳)或选自氮杂环丁烷,吡咯烷,哌啶或吖庚因的杂环(任选在氮上被烷基取代),或R1 =甲酰基或烷基羰基 并且R 2 =被COOH取代的烷基或被烷基氨基或二烷基氨基取代的烷基,其烷基可以形成杂环,或者R2是如上定义的杂环,或者相同或不同的R 1和R 2表示任选被COOH取代的烷基,烷氧基羰基 ,烷基氨基或二烷基氨基,其中烷基可形成杂环,或R 1和R 2形成氮杂环丁烷,吡咯烷,哌啶,吗啉或哌嗪环(任选被烷基取代),所有烷基具有1至5个碳原子。 这些化合物可用作抗菌剂。